ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $25,033,000 | +608.9% | 145,454 | +416.9% | 0.01% | +900.0% |
Q2 2021 | $3,531,000 | -3.8% | 28,141 | +4.0% | 0.00% | -50.0% |
Q1 2021 | $3,670,000 | +6.8% | 27,064 | +0.8% | 0.00% | 0.0% |
Q4 2020 | $3,435,000 | +13.1% | 26,848 | -0.5% | 0.00% | 0.0% |
Q3 2020 | $3,037,000 | +46.9% | 26,984 | +24.3% | 0.00% | +100.0% |
Q2 2020 | $2,068,000 | -62.5% | 21,704 | -64.6% | 0.00% | -75.0% |
Q1 2020 | $5,509,000 | +55.3% | 61,300 | -8.4% | 0.00% | +100.0% |
Q4 2019 | $3,547,000 | -23.2% | 66,900 | -42.8% | 0.00% | -33.3% |
Q3 2019 | $4,619,000 | +22.4% | 116,900 | +27.2% | 0.00% | +50.0% |
Q2 2019 | $3,775,000 | +41.2% | 91,900 | +60.1% | 0.00% | 0.0% |
Q1 2019 | $2,673,000 | +6.6% | 57,400 | -0.3% | 0.00% | 0.0% |
Q4 2018 | $2,507,000 | -29.2% | 57,555 | -7.0% | 0.00% | 0.0% |
Q3 2018 | $3,543,000 | +25.9% | 61,900 | +6.7% | 0.00% | 0.0% |
Q2 2018 | $2,814,000 | -19.5% | 58,000 | -35.1% | 0.00% | -33.3% |
Q1 2018 | $3,496,000 | +19.4% | 89,400 | +29.6% | 0.00% | +50.0% |
Q4 2017 | $2,928,000 | +81.9% | 69,000 | +59.9% | 0.00% | +100.0% |
Q3 2017 | $1,610,000 | +22.8% | 43,150 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $1,311,000 | +14.8% | 43,150 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $1,142,000 | +3.7% | 43,150 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $1,101,000 | -29.5% | 43,150 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $1,562,000 | +6.5% | 43,150 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $1,466,000 | +115.6% | 43,150 | +67.6% | 0.00% | 0.0% |
Q1 2016 | $680,000 | -42.5% | 25,750 | +6.2% | 0.00% | 0.0% |
Q4 2015 | $1,182,000 | +72.6% | 24,250 | -11.9% | 0.00% | 0.0% |
Q3 2015 | $685,000 | -79.6% | 27,520 | -74.1% | 0.00% | -66.7% |
Q2 2015 | $3,361,000 | +45.1% | 106,240 | +74.5% | 0.00% | +50.0% |
Q1 2015 | $2,317,000 | -2.3% | 60,890 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $2,372,000 | +43.2% | 60,890 | +11.1% | 0.00% | +100.0% |
Q3 2014 | $1,657,000 | +91.3% | 54,797 | +114.9% | 0.00% | 0.0% |
Q2 2014 | $866,000 | +1474.5% | 25,500 | +1493.8% | 0.00% | – |
Q1 2014 | $55,000 | -56.7% | 1,600 | -50.0% | 0.00% | – |
Q4 2013 | $127,000 | – | 3,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |